Home/Smart Money/Sofinnova Investments, Inc.
§ 13F · FUND PROFILE

Sofinnova Investments, Inc..

AUM · $1.9B (13F)Positions · 57Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$213M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS

The book · Q2 2026

FILED AUG 14, 2026
#TickerNameShares$ value% portΔ Q2
1NTRANatera Inc1.55M$421M21.8%±0%
2VERAVera Therapeutics Inc2.79M$120M6.2%±0%
3GMABGenmab A/S4.05M$111M5.7%+438%
4JAZZJazz Pharmaceuticals PLC365K$88M4.6%−39%
5RAPPRapport Therapeutics Inc1.90M$79M4.1%±0%
6SPTXSeaport Therapeutics Inc3.56M$77M4.0%NEW
7AVBPArrivent BioPharma Inc1.70M$59M3.0%±0%
8RAREUltragenyx Pharmaceutical In1.72M$57M3.0%−37%
9BIOABioAge Labs Inc2.29M$56M2.9%±0%
10BMYBristol-Myers Squibb Co877K$51M2.6%−56%
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE SOFINNOVA SIGNAL

AC read

Sofinnova Investments, Inc. is a Other fund managing $1.9 billion in assets. The fund runs a portfolio of 57 positions.

Read the full dossier →